Routine use of prophylactic antiarrhythmic therapy is not indicated ... Pharmacotherapy centers on the use of atropine at doses of 0.6 to 1.0 mg IV repeated every 5 minutes until there is the ...

The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for SYD-101 (atropine sulfate) to slow the progression of myopia in children. Considered a common ...